CA
DGX icon

Continuum Advisory’s Quest Diagnostics DGX Stock Holding History

Continuum Advisory’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-224
Closed -$37.9K – 688
2025
Q1 		$37.9K Buy
224
+222
+11,100% +$36.5K ﹤0.01% 743
2024
Q4 		$302 Hold
2
– – ﹤0.01% 1797
2024
Q3 		$314 Sell
2
-1
-33% -$149 ﹤0.01% 1850
2024
Q2 		$411 Hold
3
– – ﹤0.01% 1625
2024
Q1 		$414 Buy
+3
New +$389 ﹤0.01% 1627

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Continuum Advisory's DGX Position: Q2 2025 in Review

Continuum Advisory sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 224 shares — an estimated $37.9K sold.

Continuum Advisory first reported a position in DGX in Q1 2024 and held it in 5 quarters. The position peaked at $37.9K in Q1 2025. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Continuum Advisory reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 224 Quest Diagnostics shares in Q2 2025, an estimated $37.9K.
  • Continuum Advisory first reported a position in Quest Diagnostics in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's Quest Diagnostics position peaked at $37.9K in Q1 2025.
  • 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.